Literature DB >> 15890673

Selective expression of a dominant-negative form of peroxisome proliferator-activated receptor in keratinocytes leads to impaired epidermal healing.

L Michalik1, J N Feige, L Gelman, T Pedrazzini, H Keller, B Desvergne, W Wahli.   

Abstract

Many nuclear hormone receptors are involved in the regulation of skin homeostasis. However, their role in the epithelial compartment of the skin in stress situations, such as skin healing, has not been addressed yet. The healing of a skin wound after an injury involves three major cell types: immune cells, which are recruited to the wound bed; dermal fibroblasts; and epidermal and hair follicle keratinocytes. Our previous studies have revealed important but nonredundant roles of PPARalpha and beta/delta in the reparation of the skin after a mechanical injury in the adult mouse. However, the mesenchymal or epithelial cellular compartment in which PPARalpha and beta/delta play a role could not be determined in the null mice used, which have a germ line PPAR gene invalidation. In the present work, the role of PPARalpha was studied in keratinocytes, using transgenic mice that express a PPARalpha mutant with dominant-negative (dn) activity specifically in keratinocytes. This dn PPARalpha lacks the last 13 C terminus amino acids, binds to a PPARalpha agonist, but is unable to release the nuclear receptor corepressor and to recruit the coactivator p300. When selectively expressed in keratinocytes of transgenic mice, dn PPARalphaDelta13 causes a delay in the healing of skin wounds, accompanied by an exacerbated inflammation. This phenotype, which is similar to that observed in PPARalpha null mice, strongly suggests that during skin healing, PPARalpha is required in keratinocytes rather than in other cell types.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15890673     DOI: 10.1210/me.2005-0068

Source DB:  PubMed          Journal:  Mol Endocrinol        ISSN: 0888-8809


  11 in total

1.  Sumoylated PPARalpha mediates sex-specific gene repression and protects the liver from estrogen-induced toxicity in mice.

Authors:  Nicolas Leuenberger; Sylvain Pradervand; Walter Wahli
Journal:  J Clin Invest       Date:  2009-10       Impact factor: 14.808

Review 2.  Peroxisome proliferator-activated receptors and their ligands: entry into the post-glucocorticoid era of skin treatment?

Authors:  Günther Weindl; Monika Schäfer-Korting; Martin Schaller; Hans Christian Korting
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  A natural polymorphism in peroxisome proliferator-activated receptor-alpha hinge region attenuates transcription due to defective release of nuclear receptor corepressor from chromatin.

Authors:  Mei Hui Liu; Jun Li; Ping Shen; B Husna; E Shyong Tai; E L Yong
Journal:  Mol Endocrinol       Date:  2008-02-21

4.  PPARalpha/gamma expression and activity in mouse and human melanocytes and melanoma cells.

Authors:  Linda L Eastham; Caroline N Mills; Richard M Niles
Journal:  Pharm Res       Date:  2008-06       Impact factor: 4.200

5.  Src is activated by the nuclear receptor peroxisome proliferator-activated receptor β/δ in ultraviolet radiation-induced skin cancer.

Authors:  Alexandra Montagner; Maria B Delgado; Corinne Tallichet-Blanc; Jeremy S K Chan; Ming K Sng; Hélén Mottaz; Gwendoline Degueurce; Yannick Lippi; Catherine Moret; Michael Baruchet; Maria Antsiferova; Sabine Werner; Daniel Hohl; Talal Al Saati; Pierre J Farmer; Nguan S Tan; Liliane Michalik; Walter Wahli
Journal:  EMBO Mol Med       Date:  2014-01       Impact factor: 12.137

6.  PPARβ/δ and PPARγ maintain undifferentiated phenotypes of mouse adult neural precursor cells from the subventricular zone.

Authors:  Carolina Bernal; Claudia Araya; Verónica Palma; Miguel Bronfman
Journal:  Front Cell Neurosci       Date:  2015-03-18       Impact factor: 5.505

7.  Ligand modulated antagonism of PPARgamma by genomic and non-genomic actions of PPARdelta.

Authors:  Mattias C U Gustafsson; Deborah Knight; Colin N A Palmer
Journal:  PLoS One       Date:  2009-09-16       Impact factor: 3.240

8.  PPARs Mediate Lipid Signaling in Inflammation and Cancer.

Authors:  Liliane Michalik; Walter Wahli
Journal:  PPAR Res       Date:  2008-12-21       Impact factor: 4.964

Review 9.  FOXO1, TGF-β regulation and wound healing.

Authors:  Alhassan Hameedaldeen; Jian Liu; Angelika Batres; Gabrielle S Graves; Dana T Graves
Journal:  Int J Mol Sci       Date:  2014-09-15       Impact factor: 5.923

Review 10.  Influence of the Periodontal Disease, the Most Prevalent Inflammatory Event, in Peroxisome Proliferator-Activated Receptors Linking Nutrition and Energy Metabolism.

Authors:  Lourdes Román-Malo; Pedro Bullon
Journal:  Int J Mol Sci       Date:  2017-07-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.